
Opinion|Videos|March 21, 2025
Integrating Bispecific Antibodies in Community Oncology: Benefits and Considerations
Experts discuss the benefits of implementing and operationalizing bispecifics in the community oncology setting.
Advertisement
Episodes in this series

Video content above is prompted by the following:
What are the benefits of implementing/operationalizing bispecifics in the community oncology setting?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Bills to Address Expiring ACA Subsidies Fail to Pass Senate
2
Advancing Early Detection and Equitable Access in Alzheimer Disease Care
3
ICYMI: Highlights From SPD 2025
4
In CLL, New Therapies Offer Potential for Personalized Approaches
5











































